Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer CenterTroy Z. Horvat, Paul B. Chapman, Michael A. Postow et al.|Journal of Clinical Oncology|2015Cited by 1.1k
Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and SurgeryMartin R. Weiser, Marsha Reyngold, Joanne F. Chou et al.|JAMA Network Open|2021Cited by 31